Navigation Links
National Lung Cancer Partnership announces winner of 2007 Career Development Award
Date:3/16/2008

MADISON, Wis. National Lung Cancer Partnership is pleased to announce that Adam Marcus, Ph.D., of the Winship Cancer Institute at Emory University is the winner of the organizations 2007 Career Development Award.

The Career Development Award, in the amount of $80,000, provides two years of protected time for newly independent investigators to develop their careers in lung cancer research. With the support of the Lilly Foundation and our very generous donors, were able to offer lung cancer researchers this critical period of time to further their investigation of this deadly disease, said Regina Vidaver, executive director of National Lung Cancer Partnership.

The award will support Dr. Marcus research into how lung cancer cells are able to invade surrounding tissues. He will focus on the how mutations of the LKB1 cellular protein cause lung cancer cells to move into other tissues and how these cell mutations can affect the sensitivity of lung cancer cells to chemotherapy drugs.

By understanding how LKB1 contributes to lung cancer invasion, our research could potentially impact the development of novel diagnostic and prognostic approaches to control lung cancer malignancy, said Dr. Marcus.

Lung cancer research is severely under-funded at the federal level in proportion to the death toll from this disease. National Lung Cancer Partnership grants support scientists who choose to pursue lung cancer research, even in the face of a poor funding climate.


'/>"/>

Contact: Sara Conley
sconley@pcipr.com
312-558-1770
National Lung Cancer Partnership
Source:Eurekalert

Page: 1

Related biology news :

1. Wolves find happy hunting grounds in Yellowstone National Park
2. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
3. ESMO International Symposium on Immunology
4. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
5. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
6. Director of National Intelligence to Speak at Conference
7. Singapore National Science and Technology Awards
8. Conservation International and Toyota partner to protect Philippines rain forests
9. International team shows mercury concentrations in fish respond quickly to increased deposition
10. International team shows mercury concentrations in fish respond quickly to increased deposition
11. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ELPHIA, NOVEMBER 9, 2009 A nutritionist whose re...ables to the federal Women, Infants and Children (...Agnes Higgins Award for outstanding achievement in... Harrison, Ph.D., MNS, , a professor in the Depart...y of California, Los Angeles School of Public Heal...
(Date:11/8/2009)...STON - (Nov. 8, 2009) The loss of a gene through ...ssociated with significant abnormalities in learni...led by Baylor College of Medicine ( www.bcm.edu ) ...al Nature Genetics . , "This research goes abou...in a specific group of individuals to this gene," ...
(Date:11/6/2009)...X, Va.Registration is now open for the Society of ...ional Oncology (IO) Therapies" Webinar, which will...anscatheter treatment of liver tumors, kidney tumo...nal organization of physicians, scientists and all...blic health through pioneering advances in image-g...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Developmental delay could stem from nicotinic receptor deletion 2Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 1Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 2Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 3Oracle Focuses on Health Sciences Partner Enablement Growth and Accreditation 49591 4Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 1Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 2Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer 49588 3
...ce penicillin, a byproduct of a fungal mold, was d...gi for other breakthrough drugs. As reported Jan....m led by a University of Wisconsin-Madison researc...ongoing quest for medically useful compounds in fu...the team, led by professor of plant pathology and ...
...ence is emerging that climate change could reduce ...lso international efforts to cut poverty. However,...dy providing researchers with some of the tools th...oid the worst effects of the problem. , The new kn...wing scientists to both develop new rice varieties...
... 2005 may have been the warmest year in a century,... data from around the world. , Climatologists at N...n New York City noted that the highest global annu...ury was recorded in their analysis for the 2005 ca...udy climate change rank 2005 as the second warmest...
Other Biology News:Mining for gems in the fungal genome 2Mining for gems in the fungal genome 3Climate change: The rice genome to the rescue 2Climate change: The rice genome to the rescue 32005 was the warmest year in a century 2
(Date:11/9/2009)...ewswire-Asia/ -- The pharma and biotech sectors ar...anies are facing significant,pressure to change wi... calls for,lower prices and a greater regulatory b...l crisis have made the work of creating new drugs ... being forced to globalize their R&D,operation...
(Date:11/9/2009)...RNewswire/ -- Following the provision of clinical,...stration (FDA), privately,owned UK company Daval I...al.com ) has been informed that its innovative,ant...n Orphan-Drug,designation for the treatment of Amy...also known as Lou Gehrig,s disease, is the most co...
(Date:11/6/2009)...RNewswire-FirstCall/ -- BioSpecifics Technologies ...y developing first-in-class collagenase-based prod...e third quarter ended September 30, 2009. ,, "... year, the FDA,s Arthritis Advisory Committee unan...al of XIAFLEX(TM) for the treatment of Dupuytren,s...
(Date:11/6/2009)...v. 6 Calbiotech, Inc. announced to...vative Research (SBIR) Phase I contract by the U.S...r terms of the agreement, Calbiotech will develop ... of Dengue virus. ,, Dengue virus is a mosqu... to military forces deployed to tropical areas of ...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...NAPOLIS, and CAMBRIDGE, Mass., May 5 Amylin Pha...nd Company (NYSE: LLY ) and Alkermes, Inc. (Nasd...cation (NDA) for exenatide once weekly has been su...FDA). Exenatide once weekly is an investigational ...hat is injected subcutaneously and administered on...
...SCO, Calif., May 5 Rigel Pharmaceuticals, Inc. (N...or the first quarter ended March 31, 2009. , , Fo...loss of $29.9 million, or $0.82 per share, compare...re, in the first quarter of 2008. Weighted average... and 2008 were 36.7 million and 34.4 million, resp...
...hallenges separate haves and have-nots and acceler... Despite worldwide economic turmoil, the global b...performance in 2008, according to Beyond borders:...ung,s 23rd annual report on the biotech industry. ...t is placing the business model that fueled biotec...
Other Biology Technology:Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 2Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 3Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 4Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 5Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 6Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes 7Rigel Announces First Quarter 2009 Financial Results 2Rigel Announces First Quarter 2009 Financial Results 3Rigel Announces First Quarter 2009 Financial Results 4Rigel Announces First Quarter 2009 Financial Results 5Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 2Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 3Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young 4
iEMS thermal microplate holder from Thermo Scientific
Deluxe CO2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
LN2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
...se H- Reverse Transcriptase (RT) is an improved ve... a DNA polymerase that synthesizes a complementary...:DNA hybrid. This enzyme is genetically engineered...n a deletion in the RNase H active center. Like Su...
Biology Products: